MedPath

Pilot 3D Mammography Reader Study to Assess Breast Cancer Detection in 3D Versus 2D Digital Mammography

Completed
Conditions
Breast Cancer
Interventions
Device: 3D
Device: 2D
Registration Number
NCT01928992
Lead Sponsor
Fujifilm Medical Systems USA, Inc.
Brief Summary

The purpose of this pilot study is to provide credible performance estimate information in order to properly plan, design, and power a larger clinical study.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Female subjects participating in prior FMSU protocol with known clinical status
Exclusion Criteria
  • Subjects with unkown clinical status
  • Subjects not truthed in prior FMSU study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
3D3DSubjects that undergo 3D mammography
2D2DSubjects that undergo 2D mammography
Primary Outcome Measures
NameTimeMethod
Per Breast AUC1 Day

Breast AUC performance metrics to determine if 3D has improved breast cancer detection rate as compared to 2D.

Secondary Outcome Measures
NameTimeMethod
Subject Recall Rate1 Day

For Cancer and Non-Cancer Cases to determine if 3D can reduce the need for follow-up mammography and/or improve time to determination of need for a biopsy

Trial Locations

Locations (1)

ACR / Image Metrix

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath